Diff Profiles › MTBLS33_0002_00000004

G1_Mock_11_day_vs_G5_PR8_11_day

Mock_11_day vs PR8_11_day

p-value ≤ 0.05 54 significant 2025-09-26 00:00:00 Study: MTBLS33
77 Total Features
54 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS33_0002_00000004
Linked study
MTBLS33 — Lipid mediators of inflammation in BALF 3-11 days after infection with influenza.
Comparison
Mock_11_day vs PR8_11_day
Group A
Control group treated with PBS at 11 days.. Provides baseline for comparison with infected groups.
Group B
PR8 infected group at 11 days.. Represents resolution phase response to PR8 infection.
Total features tested
77
Significant features
54
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value
OTZRAYGBFWZKMX-PCCBWWKXSA-N — down 1e-06 0.000148
PPCHNRUZQWLEMF-XBOCNYGYSA-N (5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-18-hydroxyeicosa-5,8,11,14-tetraenoic acid down 0.03779 6.11e-07
ZHBVYDMSPDDAKE-UHFFFAOYSA-N — down 0.03957 8.53e-06
FFXKPSNQCPNORO-MBYQGORISA-N 19,20-dihydroxy-4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>-docosapentaenoic acid down 0.1305 1.05e-07
YUZXOJOCNGKDNI-UHFFFAOYSA-N — down 0.06566 2e-05
CIMMACURCPXICP-PNQRDDRVSA-N Prostaglandin D1 down 0.04575 7.14e-05
GPQVVJQEBXAKBJ-JPURVOHMSA-N 17,18-epoxyicosatetraenoic acid down 0.07313 4.65e-05
LRWYBGFSVUBWMO-UXNZXXPISA-N (±)-18-hydroxy-5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>,16<i>E</i>-eicosapentaenoic acid down 0.06939 0.000122
TWSWSIQAPQLDBP-DOFZRALJSA-N Adrenic acid down 0.1456 6.47e-06
LTERDCBCHFKFRI-BGKMTWLOSA-N (±)-11-HDoHE down 0.06923 0.000188